Taconic Biosciences Launches TruBIOME™ to Create Animal Models with Custom Microbiome Profiles

Udgivet den 15-04-2019  |  kl. 13:00  |  

RENSSELAER, N.Y., April 15, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the launch of TruBIOMETM, a first of its kind solution enabling the generation and maintenance of mice with custom microbiome profiles.

TruBIOMETM was developed to meet the research community's need for a microbiome solution that affords increased predictability, reproducibility, and systems biology insight within mouse model use.  It is the first and only platform that allows researchers to develop models with customized microbiota profiles and then expand to produce study cohorts with similar microbiomes via natural mating, all while monitored with extensive quality controls.

The TruBIOMETM solution also includes the Taconic Microbiota Repository™, a collection of defined microbiome profiles.  The collection currently includes the Wild Mouse gut microbiome licensed from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and Altered Schaedler Flora (ASF).  Having defined microbiomes provides customers with a basis for comparison to better understand the microbiome of their research models.

The attrition rate of potential therapeutics is high on the path to becoming an approved drug, with over 90% of molecules discovered using traditional techniques failing in human clinical trials according to a recent article in Forbes. Scientists constantly pursue ways to improve these odds through the understanding and control of variables.  The microbiome has been identified as a contributor to experimental variability.  Researchers conducting microbiome studies and those pursuing general drug discovery need to better understand the microbiome's impact.  Understanding the microbiome will not only provide insight into potential confounding variables, but also could lead to identifying new drug targets.

"Decades of experience leading the industry in commercial germ-free mouse production, germ-free derivation, and gnotobiotic husbandry services provide Taconic with a strong foundation to enable customers to access the solutions they need to address microbiome research challenges," expresses Nancy Sandy, chief executive officer at Taconic.  "The launch of TruBIOMETM is exciting because it is gives researchers the ability to learn how microbial variability impacts their animal model experiments."

TruBIOMETM complements Taconic's existing microbiome platform, which includes germ-free mice, germ-free derivations, and custom microbiota associations

To learn more about Taconic's microbiome solutions portfolio, please call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@taconic.com.

About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Media Contact:
Kelly Owen Grover
Director of Marketing Communications
(518) 697-3824
kelly.grover@taconic.com

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

06:36 Japansk inflation stiger fortsat i langt højere tempo end centralbankens mål
06:32 Asien: Investorerne sværmer om Hongkong-aktierne
06:32 Valuta: Dollargevinsten fra Trump-effekten fordampet
06:32 USA/T-bond: Lange rente faldt efter skuffende nyheder
06:32 USA/lukning: Walmart-skuffelse trak aktier ned - men Nvidia, Apple, Microsoft steg
06:30 Kalender med link - fredag den 21. februar
17:54 Europa/lukning: Carrefour blev ekspederet mod udgangen efter trist prognose i rødt marked
17:18 Torsdagens obligationer: Renten faldt let på dag med taler og vigende nøgletal
17:14 ISS belønnet med tredjestørste stigning nogensinde oven på stærkt årsregnskab
17:05 Torsdagens aktier: ISS i tredjestørste stigning nogensinde mens Cbrain blev straffet
16:22 Europæisk forbrugertillid voksede mere end ventet
15:45 Amazon køber rettigheder til James Bond
15:41 USA/åbning: Amerikanske aktier dykker fra rekord - Walmart og Palantir sendes ned
14:25 Genmab får godkendt kræfthåb til endnu en lymfekræftform i Japan
14:22 USA/tendens: Amerikanske aktier bakker minimalt fra rekord efter ny usikkerhed
14:07 Rovsing er ramt af forsinkelser hos kunder: Overvejer salg af nye aktier
13:10 Amerikansk detailkæmpe skuffer med prognosen: Aktien sendes kraftigt ned
13:05 Europa/aktier: Carrefour ekspederes mod udgangen efter trist prognose - ISS trækker op
12:36 Carrefour slås tilbage til 2020 efter "trist" prognose for 2025
12:25 Obligationer/middag: Renter handler sidelæns før tillidstal og flere taler